Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Standards
|
Mavacamten for treating symptomatic obstructive hypertrophic cardiomyopathyNICE Guidance, 2023Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
2 |
Material Type: Standards
|
Tafamidis for treating transthyretin amyloidosis with cardiomyopathyNICE Guidance, 2021Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
3 |
Material Type: Standards
|
Bayesian Inference-Based Gaussian Mixture Models With Optimal Components Estimation Towards Large-Scale Synthetic Data Generation for In Silico Clinical TrialsEngineering in Medicine and Biology, IEEE Open Journal of, 2022, Vol.3, p.108-1142020 IEEE ;DOI: 10.1109/OJEMB.2022.3181796Full text available |
|
4 |
Material Type: Standards
|
Patisiran for treating hereditary transthyretin amyloidosisNICE Guidance, 2019Copyrights: © NICE 2019 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
5 |
Material Type: Standards
|
Inotersen for treating hereditary transthyretin amyloidosisNICE Guidance, 2019Copyrights: © NICE 2019 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |